In this issue of Blood, Zappasodi et al show that heat-shock protein 105 (HSP105/HSPH1) is preferentially expressed in aggressive B-cell lymphomas, it modulates BCL-6 and c-Myc expression, and its inhibition reduces the tumor growth in vivo, suggesting a novel target for aggressive B-cell lymphoma.1
CITATION STYLE
Briones, J. (2015, March 12). Heat-shock proteins: A c-Myc lymphoma target? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-01-622191
Mendeley helps you to discover research relevant for your work.